LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 1.07 $ 0.00 (0 %)    

Monday, 17-Nov-2025 08:22:50 EST
QQQ $ 607.71 $ 0.00 (0 %)
DIA $ 470.99 $ 0.00 (0 %)
SPY $ 670.66 $ 0.00 (0 %)
TLT $ 88.97 $ 0.00 (0 %)
GLD $ 374.17 $ 0.00 (0 %)
$ 1.07
$ 1.05
$ 1.07 x 100
$ 1.10 x 200
-- - --
$ 1.02 - $ 33.66
379,365
na
28.9M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 10-04-2025 06-30-2025 10-Q
3 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-bl...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. has entered into a Memorandum of Understanding (MOU) to form a research and development consortium with ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION